Table 2.

Medication intake of patients.

Study	Medication intake (Control: LVHIIT), n
Alvarez et al.	Metformin 10:13; Glibenclamide 8:12; ACE inhibitor 3:3; Levothyroxine 1:1.
Winding et al.	Metformin 6:1; DPP-4 inhibitor 0:3; Sulfonylureas 1:3; GLP-1 analogues 1:2.
Afousi et al.	Diuretic 8:9; ACE inhibitors 5:4; Angiotensin blockers 4:3; Metformin10:9; Sulfonylureas 8:8; DPP-4 inhibitors 4:6; Statins 7:8.
Way et al.	Anti-Hyperglycemic 12:11; Anti-Hypertensive 8:6; Lipid Lowering 5:7.
Li et al.	Metformin 7:6; Sulfonylureas 3:3; DPP-4 inhibitors 2:3; Alpha-glucosidase inhibitor0:1.